Jan Pilebjer
Président chez Implexion Pharma AB
Profil
Jan Pilebjer is currently the Chairman at Implexion Pharma AB and a Director at Ondosis AB, VOC Diagnostics AB, and STB INN AB.
He has previously worked as a Director at Emotra AB and Pexa AB, and as a Deputy Director at Cereno Scientific AB.
Mr. Pilebjer received his undergraduate degree from the University of Uppsala.
Postes actifs de Jan Pilebjer
| Sociétés | Poste | Début |
|---|---|---|
Implexion Pharma AB
 Implexion Pharma AB Miscellaneous Commercial ServicesCommercial Services Implexion Pharma AB is a Swedish company that focuses on researching and developing drugs. The company is based in Gothenburg, Sweden. | Président | 01/02/2019 |
Ondosis AB
 Ondosis AB Pharmaceuticals: MajorHealth Technology Ondosis AB delivers flexible and individualized dosing of oral medicines formulated as micro units. The company was founded by Martin Olovsson in 2017 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | - |
VOC Diagnostics AB
 VOC Diagnostics AB Medical/Nursing ServicesHealth Services VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | - |
Strandbacka Medical
 Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jan Pilebjer
| Sociétés | Poste | Fin |
|---|---|---|
| EMOTRA AB (PUBL) | Directeur/Membre du Conseil | 08/10/2021 |
| CERENO SCIENTIFIC AB | Corporate Officer/Principal | - |
| PEXA AB | Directeur/Membre du Conseil | - |
Formation de Jan Pilebjer
| University of Uppsala | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PEXA AB | Health Technology |
| CERENO SCIENTIFIC AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Emotra AB
 Emotra AB Medical SpecialtiesHealth Technology Emotra AB engages in the research and development of physiological and statistical methods for psychiatric care. It offers a medical device that tests the psychophysiological being of patients suffering from depression through their responses to sound signals. The company was founded by Elizabeth Kaminski and Lars-Håkan Thorell on June 18, 2001 and is headquartered in Molndal, Sweden. | Health Technology |
Ondosis AB
Ondosis AB Pharmaceuticals: MajorHealth Technology Ondosis AB delivers flexible and individualized dosing of oral medicines formulated as micro units. The company was founded by Martin Olovsson in 2017 and is headquartered in Gothenburg, Sweden. | Health Technology |
VOC Diagnostics AB
VOC Diagnostics AB Medical/Nursing ServicesHealth Services VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden. | Health Services |
Implexion Pharma AB
Implexion Pharma AB Miscellaneous Commercial ServicesCommercial Services Implexion Pharma AB is a Swedish company that focuses on researching and developing drugs. The company is based in Gothenburg, Sweden. | Commercial Services |
Strandbacka Medical
Strandbacka Medical Medical SpecialtiesHealth Technology Strandbacka Medical is a Swedish company that is revolutionizing the assessment of patients with abdominal pain. The company is based in Varberg, Sweden. The company is developing a novel medical device called Perisign, which aids healthcare professionals in making a fast, objective, and correct assessment of patients with acute abdominal pain. Perisign evaluates patients within minutes and determines if they need further investigations, medical treatment, surgery, or if it is safe to go home. The device detects if the patient suffers from peritonitis, the physiological response to severe intraabdominal illness. This decreases the need for X-ray investigations and makes the subjective, manual investigation objective, increasing ER throughput. The company was founded in 2020 by Ingrid Jonsson and Andreas Jonsson. Andreas Jonsson has been the CEO since 2020. | Health Technology |